falsefalse

Hepatocellular Carcinoma (HCC): Recent Updates and Evolving Treatment Paradigms - Episode 16

Future of Advanced HCC Treatment

Dr R. Katie Kelley highlights other abstracts presented at World GI 2023 and shares what she looks forward to in the future of advanced hepatocellular carcinoma treatment.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Overview of Hepatocellular Carcinoma (HCC)
    EP. 2: Diagnosing Patients With Hepatocellular Carcinoma
    EP. 3: Factoring Stage and Hepatic Function Into Treatment Decision-Making for HCC
    EP. 4: Treatment Approaches for Patients With Early-Stage HCC
    EP. 5: The Role of Adjuvant Therapy in Patients With Early-Stage HCC
    EP. 6: Updates in First-Line Systemic Therapy for Advanced HCC: The IMbrave150 Trial
    EP. 7: Updates in First-Line Systemic Therapy for Advanced HCC: The HIMALAYA Study
    EP. 8: Optimal Sequencing in Patients With Advanced HCC
    EP. 9: Safety Profiles of Available Therapies in Advanced HCC
    EP. 10: The Future of HCC Treatment
    EP. 11: First-Line Systemic Treatment Options for Patients With Advanced HCC
    EP. 12: Tremelimumab Plus Durvalumab in Patients With Advanced HCC: The HIMALAYA Study
    EP. 13: Key Safety Outcomes From Updated Analysis of HIMALAYA Trial in Advanced HCC
    EP. 14: The CELESTIAL Study: Cabozantinib Monotherapy in Advanced HCC Treatment
    EP. 15: Safety and Efficacy Data From the Retrospective Analysis of the CELESTIAL Study in Advanced HCC
    Now Viewing
    EP. 16: Future of Advanced HCC Treatment

    Related Content:

    Hepatocellular Carcinoma (HCC): Recent Updates and Evolving Treatment Paradigms
    Safety and Efficacy Data From the Retrospective Analysis of the CELESTIAL Study in Advanced HCC
    The CELESTIAL Study: Cabozantinib Monotherapy in Advanced HCC Treatment
    Key Safety Outcomes From Updated Analysis of HIMALAYA Trial in Advanced HCC
    x